Plummeting Deaths From Heart Disease in United States (1988-2018) Reflect Rise in Use of Dietary Supplements?

Region:

All Global Research articles can be read in 51 languages by activating the Translate Website button below the author’s name (only available in desktop version).

To receive Global Research’s Daily Newsletter (selected articles), click here.

Click the share button above to email/forward this article to your friends and colleagues. Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.

Global Research Referral Drive: Our Readers Are Our Lifeline

***

A new study describes how, despite deaths from heart disease plummeting in the United States over the past three decades, the benefits have mostly been seen in people with higher incomes. Among those with lower incomes, heart attack rates have either stayed the same or worsened. This pattern reflects America’s use of dietary supplements over the same period. While the number of Americans taking supplements has increased dramatically during the past thirty years, people with higher incomes remain far more likely to use them than those with lower incomes. Following the groundbreaking discovery by Dr. Matthias Rath that deficiencies of vitamin C and other nutrients are the primary cause of heart disease, it is time for the protective benefits of dietary supplements to be extended to everyone regardless of economic status.

Published in the Circulation: Cardiovascular Quality and Outcomes journal, the study examines data from national surveys involving 26,633 Americans aged between 40 and 75 years old. Overall, the trends show a clear improvement in heart disease between 1988 and 2018. But when the study participants’ economic status is taken into account, it becomes apparent that this progress was not experienced equally across all income groups. While the 10-year cardiovascular risk fell from 7.7 percent to 5.1 percent for people in the highest income group, and from 7.6 percent to 6.1 percent for those in the second-wealthiest group, the risk for people with the lowest incomes remained at more than 8 percent.

The pattern of improvement in cardiovascular health among Americans mirrors their increasing use of dietary supplements over the same period. Data from the National Center for Health Statistics (NCHS) shows that the percentage of the country’s population who used at least one dietary supplement increased from 42 percent in 1988-1994 to 53 percent in 2003-2006. By 2018 consumer surveys indicate that 75 percent of American adults were taking them. Notably, however, mirroring the finding that the country’s least-wealthiest people continue to have the greatest cardiovascular risk, socioeconomic analysis shows that adults with lower incomes are significantly less likely to use dietary supplements than those with higher incomes.

The End of Heart Disease Is Now Possible

The association between dietary supplements and the prevention of heart disease is not merely statistical. Beginning in the late 1980s, Dr. Matthias Rath published a succession of groundbreaking scientific papers describing the role of vitamin C and other nutrients in preventing heart attacks, strokes, and other cardiovascular problems. These publications included, in 1991, a landmark paper coauthored with two-time Nobel prizewinner Linus Pauling in which Dr. Rath presented the solution to the puzzle of heart disease and explained how its primary cause is vitamin C deficiency. The publication of these papers contributed to an explosion of interest in dietary supplements in the United States. This ultimately led to the passing of the Dietary Supplement Health and Education Act (DSHEA) in 1994, legislation guaranteeing free access to vitamins and other supplementary nutrients for all Americans.

By 2015, when the Dr. Rath Research Institute published a study proving that atherosclerosis is an early form of scurvy, the clinical syndrome resulting from vitamin C deficiency, it had become clear that the end of heart disease was now possible. Two years later, a review published in the Pharmaceutical Journal – a publication of Britain’s Royal Pharmaceutical Society – added fuel to the scientific fire by confirming that the cholesterol theory of heart disease was now “dead”. Pointing out that the lives of heart attack survivors participating in pharma-sponsored statin trials had been shown to be extended by an average of just 4 days, the authors stated that there was an “ethical and moral imperative” for the potential harms of these drugs to be discussed.

With three-quarters of all American adults using dietary supplements, and deaths from heart disease consequently plummeting, the cardiovascular benefits of dietary supplementation should now be extended to everyone regardless of economic status. Otherwise, the way things are headed, the American Heart Association projects that by 2035 the annual cost of the cardiovascular epidemic to the United States will exceed $1 trillion. It is therefore time for a radical change of approach. As the old saying goes, one sure sign of madness is doing the same thing repeatedly and expecting a different result.

*

Note to readers: Please click the share button above. Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.

This article was originally published on Dr. Rath Health Foundation.

Executive Director of the Dr. Rath Health Foundation and one of the coauthors of our explosive book, “The Nazi Roots of the ‘Brussels EU’”, Paul is also our expert on the Codex Alimentarius Commission and has had eye-witness experience, as an official observer delegate, at its meetings. You can find Paul on Twitter at @paulanthtaylor

He is a regular contributor to Global Research.

Featured image is from Adobe Stock


Comment on Global Research Articles on our Facebook page

Become a Member of Global Research


Articles by: Paul Anthony Taylor

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]